Search clinical trials for: Taxol
Total 834 results
-
Midwest Cardiovascular Research FoundationSpectranetics CorporationUnknownPeripheral Arterial Disease | RestenosisUnited States
-
University Hospital, Strasbourg, FranceCompletedInfiltrative Breast CancerFrance
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)SuspendedInvasive Breast Carcinoma | HER2/Neu Negative | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIC Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States
-
AmgenCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States, France, Italy, Spain, United Kingdom, Belgium, Canada, Poland, Switzerland, Korea, Republic of, Russian Federation, Hong Kong, Portugal, South Africa, Israel, Romania, Bulgaria, Greece, Australia, Sweden, Japan, Latvia and more
-
Patrick KellyCompleted
-
ARCAGY/ GINECO GROUPNovartisCompleted
-
RenJi HospitalCompletedInflammatory Breast Cancer | Invasive Ductal Breast Cancer | Tubular Breast Cancer | Mucinous Breast CancerChina
-
Dana-Farber Cancer InstituteIncyte CorporationCompletedMetastatic Breast Cancer | Recurrent Breast CancerUnited States
-
NewLink Genetics CorporationTerminated
-
Achieve Life SciencesTerminatedBreast NeoplasmUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Esophageal Carcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Stage IV Esophageal Cancer AJCC v7 | Metastatic Esophageal Squamous Cell Carcinoma | Metastatic Esophageal Adenocarcinoma | Recurrent Gastroesophageal Junction Adenocarcinoma | Recurrent Esophageal Adenocarcinoma and other conditionsUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedStage IV Breast Cancer AJCC v6 and v7United States
-
PfizerTerminatedCarcinoma, Non-Small-Cell LungUnited States
-
Oslo University HospitalActive, not recruitingBreast CancerNorway
-
Taiho Oncology, Inc.TerminatedAdvanced Solid TumorsUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | Mixed Tumor, MesodermalUnited States
-
AstraZenecaCompletedNeoplasms | Breast Cancer | Breast NeoplasmsBrazil, Bulgaria, Czech Republic, Peru, Spain, United Kingdom, Sweden, Hungary, Belgium, Canada, Italy, France, Panama, Switzerland
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted
-
Sandy SrinivasGlaxoSmithKlineCompletedBladder Cancer | Bladder (Urothelial, Transitional Cell) Cancer | Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy) | Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) | Bladder (Urothelial, Transitional Cell) Cancer Metastatic or UnresectableUnited States
-
Weill Medical College of Cornell UniversityTerminatedProstate CancerUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedTransitional Cell Carcinoma | Bladder CancerItaly
-
Sun Yat-sen UniversityActive, not recruitingNasopharyngeal CarcinomaChina
-
University of KansasNovartisWithdrawn
-
National Cancer Institute (NCI)CompletedPancreatic Ductal Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage IV Pancreatic Cancer | Pancreatic Acinar Cell CarcinomaUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); Aravive, Inc.Not yet recruitingRecurrent High Grade Uterine CancerUnited States
-
US Oncology ResearchMillennium Pharmaceuticals, Inc.Active, not recruitingBreast Cancer | Breast Tumors | Breast Carcinoma | Malignant Neoplasm of BreastUnited States
-
Irkutsk Scientific Center of the Siberian Branch...Irkutsk State Medical UniversityCompleted
-
Queen Mary University of LondonAstraZeneca; Cancer Research UKUnknownMetastatic Breast CancerKorea, Republic of, United Kingdom, Hungary, Georgia, France, Romania
-
Verastem, Inc.CompletedOvarian CancerUnited States
-
M.D. Anderson Cancer CenterCompletedMixed Tumor, MullerianUnited States
-
Floor BackesTerminatedLynch Syndrome | Recurrent Endometrial Carcinoma | Recurrent Endometrial Clear Cell Adenocarcinoma | Recurrent Endometrial Cancer | Metastatic Endometrial Cancer | Mismatch Repair Deficiency | Recurrent Uterine Corpus CarcinosarcomaUnited States
-
Floor BackesEisai Inc.CompletedFallopian Tube Carcinoma | Recurrent Endometrial Cancer | Primary Peritoneal Carcinoma | Recurrent Ovarian CancerUnited States
-
Merrimack PharmaceuticalsSanofiCompletedLocally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer, | Primary Peritoneal Cancer or Endometrial Cancer | Locally Advanced/Metastatic Her2 Non Overexpressing Breast CancerUnited States
-
National Cancer Institute (NCI)Completed
-
Bristol-Myers SquibbCompleted
-
University of Michigan Rogel Cancer CenterRecruitingBreast CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedOvarian CancerUnited States
-
University of Alabama at BirminghamNovartis PharmaceuticalsCompletedRecurrent Ovarian CancerUnited States
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung Cancer
-
Bristol-Myers SquibbCompleted
-
Floor Backes, MDActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian CarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedSmall Cell CarcinomaUnited States
-
Barbara Parker, MDOncternal Therapeutics, IncCompletedBreast NeoplasmsUnited States
-
Bristol-Myers SquibbCompletedHead and Neck CancerJapan
-
Bristol-Myers SquibbCompleted
-
Oncolytics BiotechUniversity of TexasCompletedMetastatic or Recurrent Squamous Cell Carcinoma of the LungUnited States
-
Bristol-Myers SquibbCompleted
-
Washington University School of MedicineRecruitingCutaneous AngiosarcomaUnited States
-
Daiichi Sankyo, Inc.CompletedOvarian Cancer Stage IIIC | Ovarian Cancer Stage IVUnited States